BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Tuesday, December 16, 2025
Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 5, 2004

View Archived Issues

KI-105, a novel HSGAG-mimetic compound

Read More

In vitro evaluation of the effects of DX-88 during CPB surgery

Read More

Novel DPP-IV inhibitors identified by Kotobuki researchers

Read More

Lundbeck claims new KCNQ channel activators for epilepsy and other disorders

Read More

New opioid antagonists and their use as antiobesity agents

Read More

Two novel series of PPARdelta agonists developed at Ono

Read More

New analgesic agents targeting neuropeptide FF receptors

Read More

New SGLT2 inhibitors claimed by Yamanouchi and Kotoboki

Read More

Banyu scientists prepare and test new glucokinase activators

Read More

Novel 5-HT2C receptor ligands and their use described in GSK patent

Read More

Senetek signs letter of intent to acquire IGI

Read More

ABR-215757 enters phase I trials in Sweden

Read More

Velcade designated fast track drug for relapsed & refractory mantle cell lymphoma

Read More

QVAR in Easi-Breathe inhaler launched in U.K.

Read More

MediGene concludes license agreement for cancer-killing herpes simplex viruses

Read More

Biogen Idec advances Neublastin into development for neuropathic pain

Read More

Second stage of CoFactor phase II study given green light

Read More

ChemGenex plans phase II study of Quinamed in prostate cancer

Read More

NeuGene antisense drugs shows efficacy against Ebola virus in vivo

Read More

Equity financing at StemCells to fund study in Batten disease

Read More

Femara approved for post-tamoxifen treatment of early breast cancer

Read More

FDA approves new Xenical labeling

Read More

BioVisioN achieves milestone in Novo Nordisk collaboration

Read More

All endpoints met in multiple ascending dose study of ISA-247

Read More

7TM Pharma selects preclinical candidate for obesity

Read More

Novel potent and orally active HIV integrase inhibitor described by Merck

Read More

Bacterial TTPS inhibitors reported by Johnson & Johnson

Read More

DA-7911 reported to improve synovial thickness in refractory RA

Read More

Sildenafil shows promise in the management of complications secondary to systemic sclerosis

Read More

LJP-394 maintains efficacy in SLE patients concomitantly treated with immunosuppressants

Read More

Effective sedation achieved with Aquavan Injection for endoscopic procedures

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Dec. 15, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Dec. 16, 2025.
  • Neutrophils in the bloodstream

    Neutrophils put the brakes on fat loss

    BioWorld Science
    Fat tissue balances energy by storing lipids during times of abundance and mobilizing them when needed, yet sustained metabolic stress demands mechanisms that...
  • Novo Nordisk semaglutide pill

    CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials

    BioWorld
    A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
  • Illustration of siRNA structure

    Peptidream reveals milestone in Alnylam collaboration

    BioWorld Science
    Peptidream Inc. has announced a preclinical development milestone in its collaboration with Alnylam Pharmaceuticals Inc. under their siRNA conjugate discovery...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing